Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCMQS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,876
Award facts
- Contract value 100% obligated
- $15,875.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,875.58 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 20 mg tablets (60-count units), with an ultimate completion date of May 1, 2025. This firm fixed-price delivery order represents a direct pharmaceutical supply transaction under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, a $500 million vehicle effective through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities. The award carries no set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete on open market terms while leveraging its established position as a critical supplier within the federal pharmaceutical supply chain.
DMS Pharmaceutical Group Inc. specializes in distributing branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's extensive portfolio under its DLA contract encompasses injectable medications, tablets, specialty pharmaceuticals, and other medical supplies supporting the medical needs of military treatment facilities globally. This delivery order for Jakafi, a prescription medication used in hematologic treatment, exemplifies the company's core business of fulfilling targeted pharmaceutical requirements for federal healthcare systems through firm fixed-price mechanisms that provide cost certainty to the government.
Quick answers
Who was awarded contract SPE2DB25FCMQS?
SPE2DB25FCMQS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 30, 2025.
How much is contract SPE2DB25FCMQS worth?
The government has obligated $15,876 on SPE2DB25FCMQS.
Is contract SPE2DB25FCMQS an order under another contract?
Yes. SPE2DB25FCMQS is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMQS competed?
The extent of competition for SPE2DB25FCMQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award